4 unchanged sentences
Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives.
−Removed: Based upon our evaluation, our CEO and CFO concluded that our disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act, as amended, is recorded, processed, summarized and reported within the time periods specified in the
−Removed: applicable rules and forms, and that it is accumulated and communicated to our management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure.
+Added: Based upon our evaluation, our CEO and CFO concluded that our disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act, as amended, is recorded, processed, summarized and reported within the time periods specified in the applicable rules and forms, and that it is accumulated and communicated to our management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure.
Management’s Report on Internal Control over Financial Reporting
3 unchanged sentences
Other Information
−Removed: On February 11, 2020, the Board of the Company amended the Company’s Amended and Restated Bylaws (the “Bylaws”) to implement a proxy access provision.
−Removed: The Bylaws include a new Section 1.3, which permits a stockholder, or a group of up to 20 stockholders, owning 3% or more of the Company’s outstanding common stock continuously for at least three years to nominate and include in the Company’s proxy materials director candidates constituting up to the greater of 2 nominees or 20% of the Board, subject to the terms and conditions set forth in the Bylaws.
−Removed: The foregoing description of the amendments to the Bylaws does not purport to be complete and is qualified in its entirety by reference to the full text of the Bylaws, a copy of which is attached hereto as Exhibit 3.2 and is incorporated herein by reference.
+Added: Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
+Added: Not applicable.
Directors, Executive Officers and Corporate Governance
Information required by this Item, other than the information regarding the executive officers of the Company set forth below, is incorporated by reference to the sections of our definitive Proxy Statement for our 2022 Annual Meeting of Stockholders (the “2022 Proxy Statement”) entitled “Proposal No.
−Removed: Election of Directors”, “IQVIA’s Corporate Governance—Documents Establishing our Corporate Governance” and “IQVIA’s Corporate Governance—Committees of the Board.”
+Added: Election of Directors”, “Corporate Governance—Documents Establishing our Corporate Governance” and “Corporate Governance—Committees of the Board.”
The current executive officers of the Company are as follows:
24 unchanged sentences
Bruehlman previously served as Senior Vice President and Chief Financial Officer of IMS Health from July 2011 until the merger of IMS Health and Quintiles in 2016.
−Removed: Bruehlman also currently serves as Chairman of the Board of Directors at Q2 Solutions, an IQVIA and Quest Diagnostics joint venture.
Prior to joining IMS Health, Mr.
−Removed: Bruehlman worked for 23 years at UTC, advancing through finance positions of increasing responsibility, culminating in his appointment as Vice President, Business Development, which he held from June 2009 to April 2011, where he led the company’s global strategy and development activities.
+Added: Bruehlman worked for 23 years at UTC, advancing through finance positions of increasing responsibility, culminating in his appointment as Vice President, Business Development, which he held from June 2009 to April 2011, where he led the company’s global strategy and corporate development activities.
From June 2005 until May 2008, he was Vice President and Chief Financial Officer of Carrier Corporation.
1 unchanged sentence
Bruehlman was Vice President, Financial Planning and Analysis for UTC and also served as Director, Investor Relations of UTC.
−Removed: Bruehlman has served as a director of The Connecticut Forum since 2005.
+Added: Bruehlman served as a director of The Connecticut Forum from 2005 to 2015.
He also served as a director of The New England Air Museum from 2009 through 2013.
37 unchanged sentences
Plan Category Number of Securities
−Removed: to be issued Upon Exercise of Outstanding Options, Warrants and Rights (a)
−Removed: Weighted Average Exercise Price of Outstanding Options,Warrants and Rights (b)
−Removed: Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (excluding securities reflected in column (a) (c)
+Added: to be issued Upon Exercise of Outstanding Options, Warrants and Rights (a) Weighted Average Exercise Price of Outstanding Options, Warrants and Rights (b) Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (excluding securities reflected in column (a) (c)
Equity compensation plans approved by security holders 5,817,500 (1)
$ 116.45 (3) 10,013,585 (4)
−Removed: $ 105.50 (3) 10,700,716 (4)
Equity compensation plans not approved by security holders 26,727 (2)
2 unchanged sentences
(i) 4,326,554 shares of common stock issuable upon the exercise of outstanding time-based stock options and underlying outstanding time-based SARs;
−Removed: (ii) 571,506 shares of common stock issuable in settlement of outstanding restricted stock units awarded;
+Added: (ii) 818,185 shares of common stock issuable in settlement
+Added: of outstanding restricted stock units awarded;
(iii) 670,160 shares of common stock issuable in settlement of outstanding performance units awarded;
and (iv) 2,601 shares of deferred common stock outstanding under the Director Deferral Plan.
−Removed: Excludes (i) 127,292 shares of common stock subject to outstanding awards of restricted stock.
(2) Consists of outstanding awards issued to certain executives with supplemental pension benefits in accordance with their individual employment arrangements under the IMS Health DCERP.
−Removed: (3) The weighted-average exercise price includes all outstanding stock options and SARs but does not include restricted stock units, restricted stock, performance units or performance stock, deferred stock or IMS Health DCERP awards, all of which do not have an exercise price.
+Added: (3) The weighted-average exercise price includes all outstanding stock options and SARs but does not include restricted stock units, performance units, deferred stock or IMS Health DCERP awards, all of which do not have an exercise price.
If restricted stock units, performance units and other awards that constitute “rights” were included in this calculation, treating such awards as having an exercise price of $0, the weighted average exercise price of outstanding options, warrants and rights would be $86.61.
3 unchanged sentences
Certain Relationships and Related Transactions and Director Independence
−Removed: The information required by this item is set forth under the headings “IQVIA’s Corporate Governance,” and “Certain Relationships and Related Party Transactions” in the 2021 Proxy Statement and is incorporated herein by reference.
+Added: The information required by this item is set forth under the headings “Corporate Governance,” and “Certain Relationships and Related Party Transactions” in the 2022 Proxy Statement and is incorporated herein by reference.
Principal Accountant Fees and Services
6 unchanged sentences
Management’s Report on Internal Control over Financial Reporting
−Removed: Report of Independent Registered Public Accounting Firm
+Added: Report of Independent Registered Public Accounting Firm (PCAOB ID:
Consolidated Statements of Income
−Removed: Consolidated Statements of Comprehensive (Loss) Income
+Added: Consolidated Statements of Comprehensive Income
Consolidated Balance Sheets
Consolidated Statements of Cash Flows
−Removed: Consolidated Statements of Stockholders’ Equity (Deficit)
+Added: Consolidated Statements of Stockholders’ Equity
Notes to Consolidated Financial Statements
15 unchanged sentences
2.1 May 3, 2016
−Removed: 3.1 Amended and Restated Certificate of Incorporation of IQVIA Holdings Inc., effective November 6, 2017 (as amended through November 6, 2017).
−Removed: 3.1 February 16, 2018
−Removed: 3.2 Amended and Restated Bylaws of IQVIA Holdings Inc., effective February 11, 2020.
+Added: 3.1 Amended and Restated Certificate of Incorporation of IQVIA Holdings Inc., effective April 13, 2021 .
8-K 001-35907
−Removed: 3.2 February 18, 2020
−Removed: 4.1 Specimen Common Stock Certificate of Quintiles Transnational Holdings Inc.
3.1 April 16, 2021
+Added: 3.2 Amended and Restated Bylaws of IQVIA Holdings Inc., effective February 11, 2020 .
+Added: 10-K 001-35907 3.2 February 18, 2020
+Added: 4.1 Specimen Common Stock Certificate of Quintiles Transnational Holdings Inc .
+Added: S-1/A 333-186708 4.1 April 26, 2013
4.2 Indenture, dated as of September 28, 2016, among Quintiles IMS Incorporated, the Guarantors listed therein and U.S.
Bank National Association, as Trustee.
−Removed: 4.1 October 3, 2016
−Removed: 4.8 Indenture, dated February 28, 2017, among Quintiles IMS Incorporated, as Issuer, U.S.
−Removed: Bank National Association, as trustee of the Notes, and certain subsidiaries of the Issuer as guarantors.
−Removed: 4.1 February 28, 2017
+Added: 8-K 001-35907 4.1 October 3, 2016
4.3 Indenture, dated September 14, 2017, among Quintiles IMS Incorporated, as Issuer, U.S.
+Added: Bank National Association, as trustee of the Notes, and certain subsidiaries of the Issuer as guarantors U.S.
Bank National Association, as trustee of the Notes, and certain subsidiaries of the Issuer as guarantors.
−Removed: 4.1 September 19, 2017
+Added: 8-K 001-35907 4.1 September 19, 2017
4.4 Indenture, dated May 10, 2019, among IQVIA Inc., as Issuer, U.S.
−Removed: Bank National Association, as trustee of the Notes and certain subsidiaries of the Issuer, as guarantors.
+Added: Bank National Association, as trustee of the Notes and certain subsidiaries of the Issuer, as guarantors Association, as trustee of the Notes and certain subsidiaries of the Issuer, as guarantors.
+Added: 8-K 001-35907
4.1 May 10, 2019
4.5 Indenture, dated August 13, 2019, among IQVIA Inc., as Issuer, U.S.
−Removed: Bank National Association, as trustee of the Notes and certain subsidiaries of the Issuer, as guarantors.
−Removed: 4.1 August 13, 2019
+Added: Bank National Association, as trustee of the Notes and certain subsidiaries of the Issuer, as guarantors Association, as trustee of the Notes and certain subsidiaries of the Issuer, as guarantors.
+Added: 8-K 001-35907 4.1 August 13, 2019
4.6 Indenture, dated June 24, 2020, among IQVIA Inc., as Issuer, U.S.
Bank National Association, as trustee of the Notes and certain subsidiaries of the Issuer, as guarantors.
−Removed: 8-K 001-35907
−Removed: 4.1 June 24, 2020
−Removed: 10.1 Fourth Amended and Restated Credit Agreement, dated as of October 3, 2016, by and among Quintiles IMS Incorporated, Quintiles IMS Holdings, Inc., the Guarantors party thereto and the Lenders party thereto (Annex B to Exhibit 10.9 filed October 3, 2016).
−Removed: 10.9 October 3, 2016
−Removed: 10.2 Amendment No.
−Removed: 1, dated March 7, 2017, to Fourth Amended and Restated Credit Agreement, dated October 3, 2016, among Quintiles IMS Incorporated, Quintiles IMS Holdings, Inc., the Guarantors party thereto, Bank of America N.A., as administrative agent and collateral agent, the Incremental Term B-1 Euro Lenders party thereto and the other Lenders party thereto.
−Removed: 10.1 March 8, 2017
−Removed: 10.3 Amendment No.
−Removed: 2, dated September 18, 2017, to Fourth Amended and Restated Credit Agreement, by and among Quintiles IMS Incorporated, Quintiles IMS Holdings, Inc., the Guarantors party thereto, Bank of America N.A., as administrative agent and collateral agent, the Incremental Term B-2 Dollar Lenders party thereto and the other Lenders party thereto.
−Removed: 10.1 September 19, 2017
−Removed: 10.4 Amendment No.
−Removed: 3, dated April 6, 2018, to Fourth Amended and Restated Credit Agreement, dated October 3, 2016, by and among IQVIA Inc., IQVIA Holdings Inc., the other Borrowers party thereto, the other Guarantors party thereto, Bank of America, N.A., as administrative agent and collateral agent, and the Incremental Revolving Credit Lenders party thereto.
−Removed: 10.1 May 4, 2018
−Removed: 10.5 Amendment No.
−Removed: 4, dated June 11, 2018, to Fourth Amended and Restated Credit Agreement, dated October 3, 2016, among IQVIA Inc., IQVIA Holdings Inc., IQVIA AG, IQVIA Solutions Japan K.K., the other guarantors party thereto, Bank of America, N.A.
−Removed: as administrative agent and as collateral agent, the Lenders party thereto, the Incremental Term B-3 Dollar Lenders party thereto and the Incremental Term B-2 Euro Lenders party thereto.
−Removed: 10.1 June 12, 2018
−Removed: 10.6 Amendment No.
−Removed: 5 to Fourth Amended and Restated Credit Agreement, dated August 9, 2019, among IQVIA Inc., IQVIA Holdings Inc., the other guarantors party thereto, Bank of America, N.A.
−Removed: as administrative agent and collateral agent, the Term B-1 Euro Lenders, the Term B-2 Euro Lenders and Goldman Sachs Bank USA, as Replacement Lender.
−Removed: 10.1 August 13, 2019
−Removed: 10.7 Amendment No.
−Removed: 6 to Fourth Amended and Restated Credit Agreement, dated December 18, 2019, among IQVIA Inc., IQVIA Holdings Inc., the other guarantors party thereto, Bank of America, N.A.
−Removed: as administrative agent and collateral agent, the Term B-2 Dollar Lenders and Bank of America N.A., as Replacement Lender.
−Removed: 10.1 December 18, 2019
−Removed: 10.8 Amendment No.
−Removed: 7 to Fourth Amended and Restated Credit Agreement, dated March 11 , 20 20 , among IQVIA Inc., IQVIA Holdings Inc., the other guarantors party thereto, Bank of America, N.A.
−Removed: as administrative agent and collateral agent, and the Incremental Term A -2 Dollar Lenders
−Removed: 10-Q 001-35907
−Removed: 10.1 April 30, 2020
−Removed: 10.9 Amendment No.
−Removed: 8 to Fourth Amended and Restated Credit Agreement, dated March 30 , 2020, among IQVIA Inc., IQVIA Holdings Inc., the other guarantors party thereto, Bank of America, N.A.
−Removed: as administrative agent and collateral agent, and the Incremental Term A-2 Dollar Lenders
−Removed: 10-Q 001-35907
−Removed: 10.2 April 30, 2020
+Added: 8-K 001-35907 4.1 June 24, 2020
+Added: 4.7 Indenture, dated March 3 , 202 1 , among IQVIA Inc., as Issuer, U.S.
+Added: Bank National Association, as trustee of the Notes and certain subsidiaries of the Issuer, as guarantors.
+Added: 8-K 001-35907 4.1 March 3, 2021
+Added: 10.1 Fifth Amended and Restated Credit Agreement, dated as of August 25, 2021, by and among IQVIA Inc., IQVIA RDS Inc., IQVIA AG, IQVIA Solutions Japan K.K., IQVIA Holdings Inc., the Guarantors party thereto and the Lenders party thereto (Annex A to Exhibit 10.1 filed August 25, 2021).
+Added: 8-K 001-35907 10.1 August 25, 2021
10.2 Amended and Restated Pledge and Security Agreement, dated as of March 17, 2014, among Healthcare Technology Intermediate Holdings, Inc., IMS Health Incorporated, each of the grantors party thereto, and Bank of America, N.A., as Administrative Agent.
−Removed: 10.33 March 24, 2014
+Added: Health S-1/A 333-193159 10.3 March 24, 2014
Guaranty, dated as of March 17, 2014, among Healthcare Technology Intermediate Holdings, Inc., as Holdings, IMS Health Incorporated, as Parent Borrower, the other Guarantors party thereto from time to time, and Bank of America, N.A., as Administrative Agent.
−Removed: 10.34 March 24, 2014
+Added: Health S-1/A 333-193159 10.3 March 24, 2014
10.4 Stockholders Agreement, dated May 3, 2016, among Quintiles Transnational Holdings Inc.
and the stockholders identified therein.
−Removed: 10.4 May 3, 2016
+Added: 8-K 001-35907 10.4 May 3, 2016
Form of Director Indemnification Agreement.
−Removed: 10.13 April 19, 2013
+Added: S-1/A 333-186708 10.1 April 19, 2013
10.6 Form of Indemnification Agreement with each of the non-management directors of Quintiles IMS Holdings Inc.
−Removed: 10.8 October 3, 2016
+Added: 8-K 001-35907 10.8 October 3, 2016
Description of Non-Employee Director Compensation, effective as of January 1, 2017.
16 unchanged sentences
2013 Stock Incentive Plan.
−Removed: 10.22 April 19, 2013
+Added: S-1/A 333-186708 10.22 April 19, 2013
Form of Award Agreement Awarding Nonqualified Stock Options to Employees under the Quintiles Transnational Holdings Inc.
2013 Stock Incentive Plan.
−Removed: 10.23 April 19, 2013
+Added: S-1/A 333-186708 10.23 April 19, 2013
10.15† Form of Award Agreement Awarding Incentive Stock Options to Employees under the Quintiles Transnational Holdings Inc.
2013 Stock Incentive Plan.
−Removed: 10.2 May 1, 2014
+Added: 10-Q 001-35907 10.2 May 1, 2014
10.16† Form of Award Agreement Awarding Nonqualified Stock Options to Non-Employee Directors under the Quintiles Transnational Holdings Inc.
2013 Stock Incentive Plan.
−Removed: 10.24 April 19, 2013
+Added: S-1/A 333-186708 10.24 April 19, 2013
Form of Award Agreement Awarding Stock Appreciation Rights under the Quintiles Transnational Holdings Inc.
2013 Stock Incentive Plan.
−Removed: 10.56 April 19, 2013
+Added: S-1/A 333-186708 10.56 April 19, 2013
Form of Award Agreement Awarding Stock Appreciation Rights under the Quintiles IMS Holdings, Inc.
2013 Stock Incentive Plan effective February 2017.
−Removed: 10.41 February 16, 2017
+Added: 10-K 001-35907 10.41 February 16, 2017
Form of Award Agreement Awarding Restricted Stock Units under the Quintiles Transnational Holdings Inc.
2013 Stock Incentive Plan prior to February 2015.
−Removed: 10.1 November 26, 2013
+Added: 8-K 001-35907 10.1 November 26, 2013
Form of Award Agreement Awarding Restricted Stock Units under the Quintiles Transnational Holdings Inc.
2013 Stock Incentive Plan effective February 2015.
−Removed: 10.34 February 12, 2015
+Added: 10-K 001-35907 10.34 February 12, 2015
Form of Award Agreement Awarding Performance Units under the Quintiles Transnational Holdings Inc.
2013 Stock Incentive Plan.
−Removed: 10.35 February 12, 2015
+Added: 10-K 001-35907 10.35 February 12, 2015
Form of Award Agreement Awarding Performance Shares under the Quintiles IMS Holdings, Inc.
2013 Stock Incentive Plan effective February 2017.
−Removed: 10.45 February 16, 2017
+Added: 10-K 001-35907 10.45 February 16, 2017
10.23† Form of Restricted Stock Award Agreement under the Quintiles Transnational Holdings Inc.
2013 Stock Incentive Plan.
−Removed: 10.3 November 3, 2016
+Added: 10-Q 001-35907 10.3 November 3, 2016
10.24† Form of Award Agreement Awarding Restricted Stock Units under the Quintiles IMS Holdings, Inc.
2013 Stock Incentive Plan effective February 2017.
−Removed: 10.47 February 16, 2017
+Added: 10-K 001-35907 10.47 February 16, 2017
10.25† Quintiles IMS Holdings, Inc.
Defined Contribution Executive Retirement Plan .
−Removed: 10.7 October 3, 2016
+Added: 8-K 001-35907 10.7 October 3, 2016
IMS Health Incorporated Defined Contribution Executive Retirement Plan, as amended and restated.
−Removed: IMS Health S-1
−Removed: 10.10 January 2, 2014
+Added: IMS Health S-1 333-193159 10.10 January 2, 2014
First Amendment to the IMS Health Incorporated Retirement Excess Plan, dated March 17, 2009.
−Removed: IMS Health S-1
−Removed: 10.12 January 2, 2014
+Added: IMS Health S-1 333-193159 10.12 January 2, 2014
Second Amendment to the IMS Health Incorporated Retirement Excess Plan, dated December 8, 2009.
−Removed: IMS Health S-1
−Removed: 10.13 January 2, 2014
+Added: IMS Health S-1 333-193159 10.13 January 2, 2014
Third Amendment to the IMS Health Incorporated Retirement Excess Plan, dated April 5, 2011.
−Removed: IMS Health S-1
−Removed: 10.14 January 2, 2014
+Added: IMS Health S-1 333-193159 10.14 January 2, 2014
Fourth Amendment to the IMS Health Incorporated Retirement Excess Plan (effective May 3, 2016).
−Removed: IMS Health 10-Q
−Removed: 10.3 July 28, 2016
+Added: IMS Health 10-Q 001-36381 10.3 July 28, 2016
Quintiles IMS Holdings, Inc.
2010 Equity Incentive Plan.
−Removed: 10.5 October 3, 2016
+Added: 8-K 001-35907 10.5 October 3, 2016
Healthcare Technology Holdings, Inc.
2010 Equity Incentive Plan, as amended and restated.
−Removed: IMS Health S-1/A
−Removed: 10.16 February 13, 2014
+Added: IMS Health S-1/A 333-193159 10.16 February 13, 2014
Form of IMS Time-and Performance-Based Stock Option Award Agreement under the 2010 Equity Incentive Plan.
−Removed: IMS Health S-1
−Removed: 10.17 January 2, 2014
+Added: IMS Health S-1 333-193159 10.17 January 2, 2014
Form of IMS Time-Based Stock Option Award Agreement under the 2010 Equity Incentive Plan.
−Removed: IMS Health S-1
−Removed: 10.18 January 2, 2014
+Added: IMS Health S-1 333-193159 10.18 January 2, 2014
Form of IMS Director Stock Option Award Agreement under the 2010 Equity Incentive Plan.
109 unchanged sentences
/s/ Emmanuel N.
−Removed: Senior Vice President, Corporate Controller
+Added: Senior Vice President, Chief Accounting Officer, Corporate Controller and Treasurer
February 16, 2022
12 unchanged sentences
Director February 16, 2022
+Added: /s/ Sheila A.
+Added: Director February 16, 2022
+Added: /s/ Leslie Wims Morris
+Added: Director February 16, 2022
+Added: Leslie Wims Morris
(2) Financial Statement Schedules
2 unchanged sentences
(PARENT COMPANY ONLY)
−Removed: CONDENSED STATEMENTS OF INCOME
−Removed: Year Ended December 31,
−Removed: (in millions) 2020 2019 2018
−Removed: Selling, general and administrative expenses $ — $ — $ 2
−Removed: Loss from operations — — ( 2 )
−Removed: Interest income — — —
−Removed: Other expense, net — — —
−Removed: Loss before income taxes and equity in earnings of subsidiary — — ( 2 )
−Removed: Income tax benefit — — ( 1 )
−Removed: (Loss) income before equity in earnings of subsidiary — — ( 1 )
−Removed: Equity in earnings of subsidiary 279 191 260
−Removed: Net income $ 279 $ 191 $ 259
−Removed: IQVIA HOLDINGS INC.
−Removed: (PARENT COMPANY ONLY)
−Removed: CONDENSED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME
+Added: CONDENSED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME
Year Ended December 31,
(in millions) 2021 2020 2019
+Added: Equity in earnings of subsidiary, net of tax $ 966 $ 279 $ 191
Net income 966 279 191
−Removed: Comprehensive income (loss) adjustments:
−Removed: Unrealized (losses) gains on derivative instruments, net of income tax expense (benefit) of $( 10 ), $ 4 and $( 5 )
−Removed: ( 30 ) ( 15 ) 1
−Removed: Defined benefit plan adjustments, net of income tax (benefit) expense of
−Removed: $( 15 ), $ 5 and $( 4 )
−Removed: ( 54 ) ( 30 ) ( 8 )
−Removed: Foreign currency translation, net of income tax (benefit) expense of $( 145 ), $( 30 ) and $ 50
−Removed: 180 ( 41 ) ( 255 )
−Removed: Reclassification adjustments:
−Removed: Losses (gains) on derivative instruments included in net income, net of income tax expense of $ 3 , $ — and $ 1
−Removed: 10 ( 1 ) ( 12 )
−Removed: Amortization of actuarial losses and prior service costs included in net income — — 1
−Removed: Comprehensive income (loss) $ 385 $ 104 $ ( 14 )
+Added: Equity in other comprehensive (loss) income of subsidiary, net of tax ( 191 ) 106 ( 87 )
+Added: Comprehensive income $ 775 $ 385 $ 104
IQVIA HOLDINGS INC.
4 unchanged sentences
Cash and cash equivalents $ 2 $ 1
−Removed: Income taxes receivable — —
−Removed: Other current assets and receivables — —
Total current assets 2 1
Investment in subsidiary 9,667 9,666
−Removed: Receivable from parent company — —
Total assets $ 9,669 $ 9,667
LIABILITIES AND STOCKHOLDERS’ EQUITY
−Removed: Current liabilities:
−Removed: Accounts payable $ — $ —
−Removed: Income taxes payable — —
−Removed: Total current liabilities — —
Investment in subsidiary $ 3,625 $ 3,664
3 unchanged sentences
Stockholders’ equity:
−Removed: Common stock and additional paid-in capital, 400.0 shares authorized at December 31, 2020 and 2019, $ 0.01 par value, 254.7 shares issued and 191.2 shares outstanding at December 31, 2020;
−Removed: 253.0 shares issued and 192.3 shares outstanding at December 31, 2019
+Added: Common stock and additional paid-in capital, 400.0 shares authorized as of December 31, 2021 and 2020, $ 0.01 par value, 255.8 shares issued and 190.6 shares outstanding as of December 31, 2021;
+Added: 254.7 shares issued and 191.2 shares outstanding as of December 31, 2020
10,777 11,095
Retained earnings 2,243 1,277
−Removed: Treasury stock, at cost, 63.5 and 60.7 shares at December 31, 2020 and 2019, respectively
+Added: Treasury stock, at cost, 65.2 and 63.5 shares as of December 31, 2021 and 2020, respectively
( 6,572 ) ( 6,166 )
−Removed: Accumulated other comprehensive (loss) income ( 205 ) ( 311 )
+Added: Accumulated other comprehensive loss ( 406 ) ( 205 )
Total stockholders’ equity 6,042 6,001
8 unchanged sentences
Adjustments to reconcile net income to cash provided by operating activities:
−Removed: Subsidiary loss ( 279 ) — 143
+Added: Equity in earnings of subsidiary ( 966 ) ( 279 ) ( 191 )
Change in operating assets and liabilities:
−Removed: Accounts payable and accrued expenses — — 2
−Removed: Income taxes payable and other liabilities — —
−Removed: Net cash provided by operating activities 191 404
−Removed: $ — $ 191 $ 404
+Added: Other operating assets and liabilities ( 1 ) — —
+Added: Net cash (used in) provided by operating activities ( 1 ) — —
Investing activities:
2 unchanged sentences
Financing activities:
−Removed: Proceeds related to employee stock purchase and option plans — — 15
−Removed: Issuance of common stock ( 44 ) 11 —
+Added: (Payments) proceeds related to employee stock option plans ( 59 ) ( 44 ) 11
Repurchase of common stock ( 406 ) ( 434 ) ( 963 )
1 unchanged sentence
Net cash used in financing activities ( 465 ) ( 479 ) ( 949 )
−Removed: Effect of foreign currency exchange rate changes on cash — — —
−Removed: (Decrease) increase in cash and cash equivalents ( 2 ) 2 —
+Added: Increase (decrease) in cash and cash equivalents 1 ( 2 ) 2
Cash and cash equivalents at beginning of period 1 3 1
4 unchanged sentences
The condensed parent company financial statements have been prepared in accordance with Rule 12-04, Schedule I of Regulation S-X as the restricted net assets of IQVIA Holdings Inc.’s (the “Company”) wholly-owned subsidiary, IQVIA Incorporated exceed 25 % of the consolidated net assets of the Company.
+Added: These condensed parent company financial statements are not the general-purpose financial statement of the reporting entity.
The ability of IQVIA Incorporated to pay dividends may be limited due to the restrictive covenants in the agreements governing its credit arrangements.
2 unchanged sentences
Refer to the consolidated financial statements and notes presented elsewhere herein for additional information and disclosures with respect to these financial statements.
−Removed: Since the Parent is part of a group that files a consolidated income tax return, in accordance with ASC 740, a portion of the consolidated amount of current and deferred income tax expense of the Company has been allocated to the Parent.
−Removed: The income tax benefit of $ 0 million, $ 0 million and $ 1 million in 2020, 2019 and 2018, respectively, represents the income tax benefit that will be or were already utilized in the Company’s consolidated United States federal and state income tax returns.
−Removed: If the Parent was not part of these consolidated income tax returns, it would not be able to recognize any income tax benefit, as it generates no revenue against which the losses could be used on a separate filer basis.
+Added: The 2019 statement of cash flow presentation has been revised to conform with current period presentation.
Below is a summary of the dividends paid to the Parent by IQVIA Incorporated in 2021, 2020 and 2019:
1 unchanged sentence
Paid in December 2021 $ 57
+Added: Paid in November 2021 89
Paid in October 2021 60
+Added: Paid in September 2021 36
+Added: Paid in August 2021 35
Paid in July 2021 25
+Added: Paid in June 2021 20
+Added: Paid in May 2021 23
+Added: Paid in April 2021 4
Paid in March 2021 51
2 unchanged sentences
Paid in December 2020 $ 81
−Removed: Paid in November 2019 255
−Removed: Paid in September 2019 74
−Removed: Paid in August 2019 239
−Removed: Paid in June 2019 94
−Removed: Paid in May 2019 140
+Added: Paid in October 2020 20
+Added: Paid in July 2020 2
Paid in March 2020 44
3 unchanged sentences
Paid in November 2019 255
−Removed: Paid in October 2018 132
Paid in September 2019 74
+Added: Paid in August 2019 239
Paid in June 2019 94
12 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.